Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
The latest dividend from ABT was $0.63 per share (ex-dividend 7/15/2026). The dividend yield over the last 12 months is 2,3%. Over the last 12 months there were 4 distributions, totalling $2.48 per share.